State Street Corp Eloxx Pharmaceuticals, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.4 - $0.72 $3,182 - $5,728	7,956 Added 4.37%	189,959 $106,000
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $7,688 - $19,964	-12,400 Reduced 6.38%	182,003 $127,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.0 $6,344 - $10,400	5,200 Added 2.75%	194,403 $317,000
Q2 2021 Aug 16, 2021	SELL	$1.35 - $3.36 $335,496 - $835,013	-248,516 Reduced 56.78%	189,203 $377,000
Q1 2021 May 17, 2021	SELL	$3.02 - $4.54 $31,927 - $47,996	-10,572 Reduced 2.36%	437,719 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$2.42 - $4.48 $7,151 - $13,238	2,955 Added 0.66%	448,291 $1.78 Million
Q3 2020 Nov 10, 2020	BUY	$2.53 - $3.4 $30,291 - $40,708	11,973 Added 2.76%	445,336 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$1.56 - $3.65 $18,709 - $43,774	11,993 Added 2.85%	433,363 $1.31 Million
Q1 2020 May 11, 2020	BUY	$1.96 - $7.96 $825,885 - $3.35 Million	421,370 New	421,370 $826,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.